SHL Telemedicine
SHL Telemedicine is an Israeli publicly traded telemedicine company developing mobile hospital-grade 12-lead ECG devices and remote cardiac monitoring services with dual-use military field cardiac diagnostics applications.
Visit WebsiteCompany Overview
SHL Telemedicine develops technologies, solutions, and advanced telemedicine services for diagnosis and monitoring of the heart and various chronic diseases. The company's flagship SmartHeart Pro is the only mobile hospital-grade full 12-lead ECG device for personal use, FDA cleared.
SHL operates 24/7 telemedicine centers in Israel and Germany, processing approximately 3 million medical interactions per year. The company collaborates with Mayo Clinic and other leading healthcare institutions, using AI and big data analytics to improve remote cardiac monitoring outcomes.
Dual-use relevance is high: the same portable hospital-grade ECG technology that enables civilian remote cardiac diagnostics can be deployed for military field medical applications, enabling combat medics to perform full 12-lead ECGs on soldiers in the field and transmit results to remote cardiologists for real-time battlefield triage decisions.
Dual-Use Assessment
Mobile hospital-grade ECG and telemedicine technology has dual-use applications in civilian remote cardiac monitoring and military field medical diagnostics for battlefield triage.
Key Technologies
- SmartHeart Pro mobile 12-lead ECG device
- AI-powered cardiac anomaly detection
- Cloud-based remote medical monitoring platform
- Real-time telemedicine data transmission
- FDA-cleared personal medical diagnostic devices
Use Cases & Applications
- Remote cardiac monitoring for chronic patients
- Emergency field ECG diagnostics
- Military combat medic cardiac triage
- Forward operating base telemedicine services
- Mass casualty event rapid cardiac screening
Strategic Value to U.S.-Israel Alliance
Enhances allied military medical capabilities with hospital-grade cardiac diagnostics deployable to the tactical edge, improving battlefield survivability.
Interested in this startup?
Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.